These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 35493294)
1. Involvement of RUVBL1 in WNT/ Zeng Y; Kong Y; Liao L; Zhu H Dis Markers; 2022; 2022():3398492. PubMed ID: 35493294 [TBL] [Abstract][Full Text] [Related]
2. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling. Yang K; Zhao J; Liu S; Man S Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977 [TBL] [Abstract][Full Text] [Related]
3. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers. Lin D; Lin B; Bhanot H; Riou R; Abt NB; Rajagopal J; Saladi SV Oral Oncol; 2020 Dec; 111():104930. PubMed ID: 32745900 [TBL] [Abstract][Full Text] [Related]
4. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma. Lin X; Ding JM; Zheng XZ; Chen JG Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277 [TBL] [Abstract][Full Text] [Related]
5. MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy. Zhang H; Shen S; Feng C; Chen G; Wang X Acta Biochim Biophys Sin (Shanghai); 2023 Aug; 55(9):1445-1455. PubMed ID: 37592847 [TBL] [Abstract][Full Text] [Related]
6. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma. Hou Z; Wu C; Tang J; Liu S; Li L Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway. Tong S; Wang X; Guo X; Lu Z J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162 [TBL] [Abstract][Full Text] [Related]
8. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling. Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088 [TBL] [Abstract][Full Text] [Related]
9. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway. Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway. Li GH; Ma ZH; Wang X Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709 [TBL] [Abstract][Full Text] [Related]
11. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway. Huang G; Chen S; Washio J; Paka Lubamba G; Takahashi N; Li C Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768316 [TBL] [Abstract][Full Text] [Related]
12. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2. Wang X; Zhang Y; Zhang S; Duan L Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169 [TBL] [Abstract][Full Text] [Related]
13. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma. Lyu Q; Jin L; Yang X; Zhang F Pathol Res Pract; 2019 May; 215(5):924-930. PubMed ID: 30777615 [TBL] [Abstract][Full Text] [Related]
14. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling. Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067 [TBL] [Abstract][Full Text] [Related]
15. Chronic restraint stress promotes the tumorigenic potential of oral squamous cell carcinoma cells by reprogramming fatty acid metabolism via CXCL3 mediated Wnt/β-catenin pathway. Lou F; Long H; Luo S; Liu Y; Pu J; Wang H; Ji P; Jin X Exp Neurol; 2023 Jan; 359():114268. PubMed ID: 36343679 [TBL] [Abstract][Full Text] [Related]
16. Notum leads to potential pro-survival of OSCC through crosstalk between Shh and Wnt/β-catenin signaling via p-GSK3β. Yang P; Li C; Zhou Q; Zhang X; Kou Y; Feng Q; Wang H; Su R; Hasegawa T; Liu H; Li M Int J Biochem Cell Biol; 2022 Dec; 153():106316. PubMed ID: 36280040 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the Tumor Suppressor Gene SPINK5 via EHMT2 Induces the Oral Squamous Cell Carcinoma Development. Sun S; Su G; Zheng X Mol Biotechnol; 2024 Feb; 66(2):208-221. PubMed ID: 37071303 [TBL] [Abstract][Full Text] [Related]
18. Wnt/β-catenin signaling pathway participates in the effect of miR-626 on oral squamous cell carcinoma by targeting RASSF4. Cui SH; Hu XD; Yan Y J Oral Pathol Med; 2021 Nov; 50(10):1005-1017. PubMed ID: 34121238 [TBL] [Abstract][Full Text] [Related]
19. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway. Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938 [TBL] [Abstract][Full Text] [Related]
20. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway. Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]